Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Per Långsved new CEO of Nordea Life & Pension

Per Långsved, current Head of Personal Banking Sweden, has been appointed CEO of Nordea Life & Pension and a member of the Asset & Wealth Management Leadership Team. Per will continue as Country Senior Executive in Sweden. He steps into his new role on 1 March 2025.Per has successfully delivered on the strategic targets set out in 2019 through his strong leadership, result orientation and customer focus. He is succeeding Petteri Änkilä who has been appointed Head of Large Corporates & Institutions and a member of Nordea’s Group Leadership Team. “I'm pleased that Per has accepted the

Form 8.3 - Anglogold Ashanti plc

FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   +--------------------------------------------------------+---------------------+|(a) Full name of discloser: |Ninety One UK Ltd |+--------------------------------------------------------+---------------------+|(b) Owner or controller of interests and short positions|  ||disclosed, if different from 1(a):

Disclosure under Chapter 9, Section 10 of the Securities Markets Act regarding change in holdings

Optomed Plc Stock Exchange Release 14 November 2024 at 11.00, Helsinki Disclosure under Chapter 9, Section 10 of the Securities Markets Act regarding change in holdings Optomed Plc (“Optomed” or the “Company”) has received a notification in accordance with the Chapter 9, Section 5 of the Finnish Securities Markets Act (as amended, the “SMA”) from Danske Bank A/S (“Notifier”). According to the notification, the total holdings in Optomed shares and votes held the by Danske Bank A/S is 4.86 per cent of all of the registered shares in Optomed on 12 November 2024.   The total number

DUG Foodtech AB and Davide Cobelli collaborates to transform the Italian coffee market

DUG Foodtech AB, a pioneering company in plant-based beverages for coffee, is excited to announce a strategic partnership with Davide Cobelli, one of Italy’s most respected figures in the coffee world.Effective today, Davide Cobelli will step in as brand ambassador for DUG in Italy, bringing his expertise and passion to baristas, roasters, and coffee enthusiasts throughout the country. This collaboration offers a unique opportunity for all sectors of the Italian coffee industry: · Baristas: Will have access to premium products and exceptional training, backed by Davide Cobelli’s

Apotea intends to list its shares on Nasdaq Stockholm

NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE PEOPLE’S REPUBLIC OF CHINA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES. PLEASE SEE “IMPORTANT INFORMATION” AT THE END OF THE PRESS RELEASE.Apotea AB (publ) [1] (“Apotea” or the “Company”), Sweden’s largest online pharmacy, announces its intention to launch an initial public offering of the Company’s ordinary

Pihlajalinna Plc: Managers’ transactions

Pihlajalinna Plc      Managers’ transactions     14 November 2024 at 10:30 a.m. Pihlajalinna Plc: Managers’ transactions Pihlajalinna Plc has received the following notification on 13 November 2024: Person subject to the notification requirementName: Seppo KariniemiPosition: Other senior manager lssuer: Pihlajalinna OyjLEI: 74370058MTRLEDOCHV67 Notification type: INITIAL NOTIFICATIONReference number: 84792/5/4 ____________________________________________ Transaction date: 2024-11-13Venue: NASDAQ HELSINKI LTD (XHEL)lnstrument type: SHAREISIN: Fl4000092556

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 246 – 14 NOVEMBER 2024   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 235/24 and 237/24.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Therese Möllevinge, Head of Investor Relations, tel.: +45 41 37 16 38, e-mail: thm@norden.com Isabella Zaugg Hansen, Investor Relations Manager, tel.: +45 27 62 90 96, e-mail: izh@norden.com

Advenica launches hardware-based cybersecurity solution that will help manufacturing companies and OEM/machine builders protect their production data

Advenica now announces a new solution for all manufacturers that need remote support with intact network integrity or machine builders that wants to offer their customers secure machine connections while still being able to offer analysis services, with minimal cybersecurity risks.With this new solution, the attack surface and exposure are minimised, providing a new level of security, while enabling digital services expected in Industry 4.0. This cybersecurity solution based on physically enforced, always open, one-way data flow combined with two-way data flow, only when needed, delivers an

Volvo Cars sells 30 per cent stake in Lynk & Co to Zeekr

Volvo Cars today announces the divestment of its 30 per cent stake in Lynk & Co to Zeekr, a transaction representing a consideration of RMB 5.4 billion (approx. SEK 8 billion). The consideration will be paid in cash, with 70 per cent of the amount paid at closing of the transaction and 30 per cent plus interest paid one year after closing. The transaction is expected to close during the first quarter of 2025. Volvo Cars has been a minority shareholder of Lynk & Co since the company was set up in 2017. The divestment is in connection with a new phase of development for Lynk & Co going

SSAB Expands Strenx® Certified Fabricator Network to United Kingdom

SSAB, a global leader in high -strength steel, is proud to announce the launch of the Strenx® Certified Fabricator, an exclusive initiative designed to recognize and promote excellence in the field of high strength steel fabrication.Strenx[®] Certified Fabricator connects a select group of fabricators with a proven ability to provide OEMs with state-of-the-art steel components and pre-fabricated structures. They have demonstrated exceptional skill and expertise in working with SSAB’s Strenx[®] performance steel. SSAB has appointed MTL Advanced Ltd, located in Rotherham, United Kingdom.

Abundance and local ingredients as Viking Line inaugurates this year’s Christmas buffet on board its vessels

Today, November 14, is the day Viking Line starts serving its lavish Christmas buffet. This year’s Christmas buffet includes more than one hundred dishes, a 25 per cent increase compared to Christmas 2023. Fish and vegetarian dishes are served alongside traditional Christmas ham, cocktail sausages and the classic Swedish potato dish Janson’s Temptation. Nearly 80 per cent of the ingredients are locally sourced.During the Christmas season, some 70 per cent of Viking Line’s passengers opt to try the Christmas buffet on board. Passengers are tempted by the convenience, tradition and tasty food.

Gothenburg increasingly dominant within Swedish R&D

Gothenburg is solidifying its position as an innovation powerhouse, with business R&D expenditure growing significantly. In 2023, companies in Gothenburg’s county, Västra Götaland, spent over SEK 9 billion more on R&D than companies in the Stockholm County. The R&D intensity in Gothenburg's county is more than twice that of Stockholm and the rest of Sweden – and the gap continues to widen.Companies in Västra Götaland are allocating more and more resources to R&D, now accounting for 35 per cent of Sweden's private R&D expenditure, according to recent statistics from Statistics Sweden (SCB).

Heimstaden Bostad AB (publ) Announces Tender Offer for Certain NOK Senior Unsecured Notes and Call for Redemption of Certain NOK and SEK Senior Unsecured Notes

Tender Offer Today, Heimstaden Bostad AB (publ) (“Heimstaden Bostad”) is launching an offer to the holders of its NOK 1,250 million floating rate notes due April 2026 (ISIN NO0010976327) - of which NOK 178,000,000 is currently held by Heimstaden Bostad -  (referred to as the “2026 Notes”) and its NOK 350 million floating rate notes due April 2028 (ISIN NO0010976335) (referred to as the “2028 Notes”), (together referred to as the “Notes”), to tender any and all of their 2026 Notes for purchase by Heimstaden Bostad for cash at a fixed purchase price of 100.00%, and any and all of their

Correction: ExpreS2ion announces financial results for the third quarter of 2024

Hørsholm, Denmark, 14 November 2024 – ExpreS2ion Biotech Holding AB (“ExpreS2ion”) today announces its third quarter and year-to-date financial results for 2024. The report is available as an attachment and on ExpreS2ion's website (www.expres2ionbio.com). Below is a summary of the report. This press release is a correction to the press release made earlier this morning, which did not include the report as an attachment.CEO Bent U. Frandsen comments: “We achieved substantial milestones in the third quarter of 2024, notably submitting the clinical trial application for our breast cancer

Commercial oil and gas discovery in the Fram area in the North Sea

Sandnes, Norway 14 November 2024: Vår Energi ASA (OSE:VAR) confirms a commercial oil and gas discovery in the Equinor operated Rhombi well in the Fram licence in the North Sea. The preliminary estimate of shows gross recoverable resources of between 13-28 million barrels of oil equivalent (mmboe).The discovery was made in two different structural segments in Sognefjord and Fensfjord formations with fair to very good reservoir characteristics. The preliminary estimate of gross recoverable resources of the discovery are between 13 – 28 million barrels of oil equivalent. The licensees regard

Aquaporin Q3 2024 Trading Statement

Company announcementNo. 19/2024 Aquaporin A/SNymøllevej 78DK-2800 Kongens Lyngbyaquaporin.comCompany registration no.: DK28315694    Copenhagen, Denmark, November 14, 2024 – Aquaporin A/S (ticker: AQP) (“Aquaporin” or the “Company”), an innovative water technology company dedicated to rethinking water filtration with biotechnology, today announces the Company's Q3 2024 Trading Statement for the period January 1-September 30, 2024.   “Despite the recent setback in our revenue guidance, we have achieved several important targets so far in 2024. We have increased the

Impero releases Q3 Report 2024: Realizes DKK 36.9M in Annual Recurring Revenue corresponding to 31% year-on-year growth and delivers positive cash flow from operating activities

Company Announcement No. 13-2024 Copenhagen, 14 November 2024 At the end of Q3 2024, Impero realized a 31% year-on-year Annual Recurring Revenue (ARR) growth, delivering the strongest absolute net-ARR growth ever both for the third quarter as well as year-to-date. Revenue for the first three quarters of 2024 increased by 29%, while capacity costs (other external expenses and staff costs) increased by 12%, contributing to the planned improvement in EBITDA and positive cash-flow from operating activities for the first nine months of 2024. Impero maintains the guidance for the full year of

BioStock: What will Cereno Scientifics 250 MSK loan mean for the shareholders?

Following the company’s positive results from the phase II trial and pivot to fully focus on rare diseases, Cereno Scientific secured a substantial loan. Watch Sten R Sörensen, CEO talk about how this will influence the business and shareholders.Watch the interview with Cereno Scientific at biostock.se:https://www.biostock.se/en/2024/11/what-will-cereno-scientifics-250-msk-loan-mean-for-the-shareholders/This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/en/

Sectra receives CSA STAR Level 2 security certificate—facilitating cloud adoption in healthcare

Linköping, Sweden – November 14, 2024 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) has received CSA STAR Level 2 certificate for its Software-as-a-Service subscription for enterprise imaging, Sectra One Cloud, following an assessment according to the framework of the Cloud Security Alliance (CSA). This highlights Sectra's ability to maintain the highest standards of security and compliance for its cloud offerings.CSA STAR (Security, Trust, Assurance, and Risk) is a certification program developed by the Cloud Security Alliance (CSA).

BoMill Q3 Report July – September 2024

BoMill AB (”BoMill” or the “Company”) hereby publishes the Interim Report for the period July 1 – September 30, 2024. The Interim Report is available as an attached file to this release and on BoMill’s website. Below is a summary of the report.Strong momentum with new orders from industry leaders in Europe and Mexico CEO Andreas Jeppsson comments: ”Our intense commercial activities and dedication supporting and working closely with our customers are paying off with new orders from both existing and new customers” Net sales and income for the third quarter (July – September 2024)

BPC Instruments reports results for the period January – September 2024

BPC Instruments (publ) hereby publishes the interim report for the period January 1—September 30, 2024. The interim report is available as an attached file to this release and on the Company’s website . Below is a summary of the report.CEO Dr. Jing Liu comments:“BPC Instruments continues to execute on its growth strategy, strengthening our position through industry partnerships and product launches. As we progress into the second half of 2024, we are pleased to report steady growth in both the biogas and the biogradability plastic sector.”

ExpreS2ion announces financial results for the third quarter of 2024

Hørsholm, Denmark, 14 November 2024 – ExpreS2ion Biotech Holding AB (“ExpreS2ion”) today announces its third quarter and year-to-date financial results for 2024. The report is available as an attachment and on ExpreS2ion's website (www.expres2ionbio.com). Below is a summary of the report.CEO Bent U. Frandsen comments: “We achieved substantial milestones in the third quarter of 2024, notably submitting the clinical trial application for our breast cancer vaccine candidate, ES2B-C001. This marks our most significant milestone for this proprietary asset. We also advanced key partnerships,

There are no items matching the current filter
There are no more items matching the current filter
Back to top